Bicara Therapeutics Inc.(BCAX) - 2025 Q4 - Annual Results

Exhibit 1.1 BICARA THERAPEUTICS INC. 7,175,000 SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE PRE-FUNDED WARRANTS TO PURCHASE UP TO 2,200,000 SHARES OF COMMON STOCK UNDERWRITING AGREEMENT c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 February 24, 2026 Morgan Stanley & Co. LLC TD Securities (USA) LLC BofA Securities, Inc. As Representatives of the several Underwriters c/o TD Securities (USA) LLC 1 Vanderbilt Avenue New York, New York 10017 c/o BofA Securities, Inc. One Bryant Park ...